Liu Arthur K, Foreman Nicholas K, Gaspar Laurie E, Trinidad Elizabeth, Handler Michael H
Department of Radiation Oncology, University of Colorado Denver, Aurora, Colorado 80045, USA.
Pediatr Blood Cancer. 2009 Jul;52(7):804-7. doi: 10.1002/pbc.21982.
Treatment failure in children with ependymoma is relatively common, with the majority of events consisting of local failure. Salvage therapy for these children historically had poor results, with repeated local recurrences. To improve these outcomes, we began to offer hypofractionated re-irradiation after resection at first local recurrence. To minimize the duration of therapy, we chose a hypofractionated regimen that has been shown to be well tolerated in adult patients.
We performed a review of the experience at the Children's Hospital in Denver and at the Department of Radiation Oncology at the University of Colorado Denver from 1995 to 2008 with hypofractionated re-irradiation after maximally safe resection in children with locally recurrent ependymoma.
Six children with locally recurrent ependymoma were seen in that time period. After maximally safe resection, all six received hypofractionated radiation therapy of 24-30 Gy delivered in three fractions. With a median follow-up of 28 months from the time of re-irradiation, all six children are alive with no evidence of disease. Three children had evidence of radiation necrosis, either clinically or based on imaging, but none required significant intervention.
Hypofractionated re-irradiation after resection for locally recurrent ependymoma is well tolerated. This approach also appears to provide good local control. Additional follow-up is required to determine the efficacy and potential late effects of hypofractionated re-irradiation in this patient population.
室管膜瘤患儿治疗失败相对常见,大多数情况为局部失败。以往这些患儿的挽救性治疗效果不佳,局部反复复发。为改善这些结果,我们开始在首次局部复发切除术后提供超分割再照射治疗。为尽量缩短治疗时间,我们选择了一种在成年患者中已显示耐受性良好的超分割方案。
我们回顾了1995年至2008年丹佛儿童医院和科罗拉多大学丹佛分校放射肿瘤学系对局部复发室管膜瘤患儿在最大安全切除术后进行超分割再照射的经验。
在该时间段内共诊治6例局部复发室管膜瘤患儿。在最大安全切除术后,所有6例患儿均接受了分3次给予24 - 30 Gy的超分割放射治疗。从再照射时起的中位随访时间为28个月,所有6例患儿均存活,无疾病证据。3例患儿有放射坏死的证据,无论是临床还是影像学表现,但均无需重大干预。
局部复发室管膜瘤切除术后的超分割再照射耐受性良好。这种方法似乎也能提供良好的局部控制。需要进一步随访以确定超分割再照射在该患者群体中的疗效和潜在的晚期效应。